FOR PHYSICIANS
Order Testing
Caris Life Sciences combines the use of sophisticated tumor profiling technologies with leading edge bioinformatics capabilities to advance precision medicine in ways that only we can. Clinicians, patients, and researchers rely on us to provide high quality and objective data to inform individual therapy decisions.
Comprehensive Molecular Profiling
We perform comprehensive bioinformatics testing on DNA, RNA and proteins at our state-of-the-art, 66,000 sq. ft. laboratory in Phoenix, Arizona. In fewer than 14 days, Caris Life Sciences assesses and packages clinically relevant information to help healthcare providers inform the creation of medical therapies that are more effective because they are tailored to specific cancer subtypes.
Download
Choose the appropriate Tumor Profiling Requisition for your region from the options below. Caris molecular profiling can only be ordered by clinicians and other medical staff, as allowed by law. If you are a patient, learn more.
Complete
- Use the appropriate Tumor Profiling Requisition to place an order.
- Use the appropriate Specimen Collection Card to submit a specimen.
Submit
Email the completed form(s) to CustomerSupport@CarisLS.com, or fax to 1.866.479.4925.
When specimen is being prepared for shipment, please include completed forms with the shipper kit.
For easy ordering, sign up for a Caris Provider Portal account.
Select Your Region
Product availability and information may vary by location. Select your region to view the products and resources available in your area.
Tissue
Tumor Tissue Sample
MI Cancer Seek®
Comprehensive molecular insights that help clarify diagnosis, guide treatment decisions, and support better outcomes for patients.
The first and only simultaneous WES/WTS-based assay with CDx indications for adult and pediatric patients (ages 1+).
ORDER NOW
DOCUMENT DOWNLOADS
Tumor Tissue Sample
MI Clarity™
AI-powered prognostic test for HR+/HER2- early-stage breast cancer.
Analyzes digitized H&E whole slide images combined with clinical inputs to stratify patients into low- and high-risk categories for both early (Years 0–5) and late (Years 5–15) distant recurrence
EARLY ACCESS ONLY
Blood
Blood Sample
Caris Assure®
Whole Blood. Whole Picture.
Caris Assure is the only liquid biopsy that analyzes both plasma and buffy coat variants, providing a more complete molecular profile.
Blood / Bone Marrow
Caris ChromoSeq™
Comprehensive genomic analysis for myeloid malignancies designed to replace conventional karyotyping, FISH, and NGS workflows.
Myeloid malignancies are complex. Genetic testing shouldn’t be. Caris ChromoSeqTM, a whole-genome sequencing assay, brings the complete molecular picture into a single test, supporting more confident diagnosis, risk stratification, and treatment decisions in myeloid malignancies.
Caris+Portal
Convenient Access to Caris Profiling
Caris+®Portal provides easy access for users to electronically submit orders, track case progress, view results and review Caris Life Sciences’ profiling information in one convenient location.
New users will select the Register link at the bottom of the login page and enter their name and their clinic or institution email address to verify the account.
Partners
EHR
Integration
Caris profiling seamlessly integrates with various Electronic Health Record (EHR) systems, enabling healthcare providers to electronically order tests and review results within their patient care platform, fostering improved patient interactions and streamlined care.
Ready to order molecular testing?
Our team is here to help you every step of the way.
Contact a Professional
